Immutep Receives Approval to Initiate INSIGHT-005 Trial Evaluating Eftilagimod Alpha and Anti-PD-L1 Therapy BAVENCIO
Posted: 1 May 2023 Immutep Limited, a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces it has received regulatory approval from the Paul-Ehrlich-Institut (“PEI”), German Federal Institute for Vaccines and Biomedicines, to…
Nominations are now open for the 2023 GSK Award for Research Excellence!
Posted: 27 April 2023 Closes: 16 June 2023 Nominations are now open for the 2023 GSK Award for Research Excellence! The GSK Award for Research Excellence (ARE) is one of the most prestigious and longstanding awards available to…
Cytiva supports BioCina with first GMP production and development facility for mRNA in Australia
Posted: 27 April 2023 Cytiva and the University of Adelaide are collaborating with BioCina, an Australian-based multi-product biologics contract development and manufacturing organization (CDMO), to expand its facility in Adelaide to manufacture mRNA-based vaccines and therapies. Fellow Danaher…
MELBOURNE SHINES AS AUSTRALIA’S PREFERRED CITY FOR MEDICAL CONFERENCES
Posted: 27 April 2023 Melbourne continues to lead the way as the preferred destination for medical conferences, with the Melbourne Convention Bureau (MCB) securing a massive 48 events to take place within the next five years. Firmly placing…
Establishment of two sub-faculties within the Faculty of Medicine, Nursing and Health Sciences and appointment of sub-faculty deans
Posted: 27 April 2023 Monash University has announced the establishment of two new sub-faculties within the Faculty of Medicine, Nursing and Health Sciences (MNHS), the Sub-Faculty of Health Sciences and the Sub-Faculty of Clinical and Molecular Medicine. Professor…
Study reveals how patients’ smoking history changes evolution of lung cancer
Posted: 27 April 2023 Understanding the differences in the evolution of lung cancer between smokers and non-smokers could be the key to unlocking new treatments. Researchers evaluated lung cancer progression in smokers, compared with people who had never smoked, and…
Landmark Malawi trial boosts iron levels in pregnant women
Posted: 27 April 2023 The World Health Organization (WHO) currently recommends oral iron taken twice daily as the standard of care in developing nations, but adherence to this treatment is poor. The finding, driven by a collaboration between…
HER2-targeted DEP SN-38 ADC outperforms in HER2+ human cancer model
Posted: 26 April 2023 Starpharma today announces that it has developed a HER2-targeted DEP® SN-38 antibody-drug conjugate (ADC), which has shown significant anti-tumour activity in a HER2+ human ovarian cancer xenograft model, outperforming the approved ADC product, Enhertu®[2]. ADCs…
AZD0466 active in small cell lung cancer patient models
Posted: 21 April 2023 Starpharma announces AZD0466 results from a preclinical study in small cell lung cancer (SCLC) patient-derived xenograft (PDX) models. Starpharma’s partner, AstraZeneca, presented these results overnight at the American Association for Cancer Research (AACR) Annual Meeting.…
International partnership launches Monash University-Helmholtz lab to solve global oncology, cardiology and infectious disease challenges
Posted: 21 April 2023 Monash University has partnered with the Helmholtz-Zentrum Dresden-Rossendorf (HZDR), a member of the Helmholtz Association of German Research Centres to establish the Monash-Helmholtz Laboratory for Radio-Immuno-Theranostics (MHELTHERA) to enable clinical translation at a launch…
ANDHealth Partners with Chicago ARC to Bring Australian Digital Health Startups into the U.S. Market
Posted: 21 April 2023 Chicago ARC Executive Director Kate Merton and ANDHealth CEO and Managing Director Bronwyn Le Grice today announced an exciting new partnership to connect Australia’s best and brightest digital health companies with U.S. partners and…
BioMelbourne Network thanks Professor Brendan Murphy
Posted: 19 April 2023 BioMelbourne Network thanks Professor Brendan Murphy AC for his outstanding contributions to health and public health in various roles, including Secretary of the Australian Government Department of Health and Aged Care. “As Chief Medical…
